BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17351158)

  • 1. Effects of statins on restenosis after coronary stent implantation.
    Kamishirado H; Inoue T; Sakuma M; Tsuda T; Hayashi T; Takayanagi K; Node K
    Angiology; 2007; 58(1):55-60. PubMed ID: 17351158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin therapy may prevent restenosis after successful coronary intervention, independent of lipid-lowering effect and CRP level.
    Yamawaki T; Yamada A; Fukumoto Y; Kishi T; Sobashima A; Kuwata K; Nakamura R; Sekiya M; Ando H; Okamatsu S
    Fukuoka Igaku Zasshi; 2007 Jun; 98(6):260-9. PubMed ID: 17665547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restenosis after successful ostial stent implantation: the role of statins compared with conventional treatment.
    Horlitz M; Amin FR; Boerrigter G; Sigwart U; Clague JR
    J Interv Cardiol; 2004 Oct; 17(5):301-6. PubMed ID: 15491333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-eluting stent for the treatment of small coronary lesion: comparison between sirolimus- and paclitaxel-eluting stent.
    Li JJ; Xu B; Yang YJ; Chen JL; Qiao SB; Ma WH; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2007 Apr; 120(7):569-73. PubMed ID: 17442204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined treatment with statin and angiotensin-receptor blocker after stenting as a useful strategy for prevention of coronary restenosis.
    Nishikawa H; Miura S; Shimomura H; Tsujita K; Okamura K; Zhang B; Iwata A; Shirai K; Matsuo K; Arai H; Saku K
    J Cardiol; 2005 Mar; 45(3):107-13. PubMed ID: 15801275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of clinical and angiographic outcomes after Excel bioabsorbable polymer versus Firebird durable polymer rapamycin-eluting stent for the treatment of coronary artery disease in a "real world" setting: six-month follow-up results.
    Liu HB; Xu B; Qiao SB; Yang YJ; Ma WH; Qin XW; Yao M; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Li JJ; Chen JL; Gao RL
    Chin Med J (Engl); 2007 Apr; 120(7):574-7. PubMed ID: 17442205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid-lowering effect of preoperative statin therapy on postoperative major adverse cardiac events after coronary artery bypass surgery.
    Thielmann M; Neuhäuser M; Marr A; Jaeger BR; Wendt D; Schuetze B; Kamler M; Massoudy P; Erbel R; Jakob H
    J Thorac Cardiovasc Surg; 2007 Nov; 134(5):1143-9. PubMed ID: 17976441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of combined treatment with angiotensin II type 1 receptor blocker and statin on stent restenosis.
    Yoshikawa M; Nakamura K; Nagase S; Sakuragi S; Kusano KF; Matsubara H; Ohe T
    J Cardiovasc Pharmacol; 2009 Feb; 53(2):179-86. PubMed ID: 19188828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrocortisone reduces restenosis after stenting of small coronary arteries.
    Kakio T; Matsumori A; Ohashi N; Yamada T; Saito T; Kawamoto A; Taguchi A; Morita Y; Takahashi M; Sasayama S
    J Interv Cardiol; 2004 Oct; 17(5):295-300. PubMed ID: 15491332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluvastatin for the prevention of restenosis after coronary balloon angioplasty: angiographic and methodological background of the fluvastatin angioplasty restenosis trial.
    Foley DP; Serruys PW
    Br J Clin Pract Suppl; 1996 Jan; 77A():40-53. PubMed ID: 8729590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial.
    Serruys PW; Foley DP; Jackson G; Bonnier H; Macaya C; Vrolix M; Branzi A; Shepherd J; Suryapranata H; de Feyter PJ; Melkert R; van Es GA; Pfister PJ
    Eur Heart J; 1999 Jan; 20(1):58-69. PubMed ID: 10075142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
    Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR
    Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of lipid levels and lipid-lowering therapy on restenosis after coronary artery stenting.
    Lerakis S; El-Chami MF; Patel AD; Veledar E; Alexopoulos E; Zacharoulis A; Triantafyllou A
    Am J Med Sci; 2006 May; 331(5):270-3. PubMed ID: 16702797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluvastatin for the prevention of restenosis after coronary balloon angioplasty: angiographic and methodological background of the fluvastatin angioplasty restenosis trial.
    Foley DP; Serruys PW
    Br J Clin Pract Suppl; 1994 Dec; (77):39-50. PubMed ID: 19496272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome does not increase angiographic restenosis rates after drug-eluting stent implantation.
    Canibus P; Faloia E; Piva T; Muçai A; Serenelli M; Perna GP; Boscaro M; Piva R
    Metabolism; 2008 May; 57(5):593-7. PubMed ID: 18442619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of significant chronic kidney disease on long-term clinical outcomes after drug-eluting stent versus bare metal stent implantation.
    Jeong YH; Hong MK; Lee CW; Park DW; Kim YH; Kim JJ; Park SW; Park SJ
    Int J Cardiol; 2008 Mar; 125(1):36-40. PubMed ID: 17521753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long term results of unprotected left main percutaneous coronary intervention with DES versus BMS.
    Capodanno D; Di Salvo ME; Capranzano P; Seminara D; Caggegi A; Barrano G; Tamburino C
    Minerva Cardioangiol; 2009 Feb; 57(1):1-6. PubMed ID: 19202514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin therapy is associated with reduced restenosis rates after coronary stent implantation in carriers of the Pl(A2)allele of the platelet glycoprotein IIIa gene.
    Walter DH; Schächinger V; Elsner M; Mach S; Dimmeler S; Auch-Schwelk W; Zeiher AM
    Eur Heart J; 2001 Apr; 22(7):587-95. PubMed ID: 11259146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of directional coronary atherectomy-based intervention and stenting alone in ostial lesions of the left anterior descending artery.
    Chung CM; Nakamura S; Katoh O
    Chang Gung Med J; 2005 Oct; 28(10):689-98. PubMed ID: 16382753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.